Life Sciences Compliance: A Strategic Imperative for Profitability & Innovation
Meet the Authors
Key Takeaways
⇨ The life sciences industry faces challenges in balancing profitability, innovation, and regulatory compliance, requiring strategic and collaborative approaches with regulatory experts and technology providers.
⇨ Pharma 4.0 reshapes compliance management, emphasizing the need for organizations to assess their digital transformation journey, analyze data strategy, and establish iterative objectives to build resilient supply chains.
⇨ NTT DATA Business Solutions provides tools like pre-configured GxP standards and the Integrated Life Science Accelerator to streamline compliance processes, integrating disparate data systems to enhance analysis and proactive risk management.
The life sciences industry operates within a highly regulated global landscape, where the delicate balance between compliance, profitability, and innovation is constantly being tested. With increasing global pricing regulations and the push for regulatory harmonization, companies face the critical challenge of adhering to stringent standards while maintaining a competitive edge and fostering groundbreaking advancements.
As Russell DeLapp, Industry Solutions Principal, Life Sciences at NTT DATA Business Solutions, emphasizes, “Balancing profitability, innovation, and regulatory compliance is a challenge that organizations must approach strategically.” This task requires a proactive and collaborative approach.
The Power of Partnership
“A critical step toward achieving long-term compliance is developing strong partnerships with regulatory experts and technology providers like NTT DATA Business Solutions,” DeLapp says. “Collaborating with these stakeholders helps companies stay ahead of new regulations and industry standards.”
Explore related questions
He gives an example to highlight this: “We have team members actively participate in regulatory panels and boards to ensure early insights into upcoming changes, enabling a proactive approach to compliance.” This ensures that NTT DATA Business Solutions remains at the forefront of regulatory shifts, allowing them to guide their clients effectively.
Beyond external partnerships, companies that weave compliance into their core processes experience smoother transitions and fewer operational disruptions when regulations evolve.
The pursuit of this balance often leads to innovative solutions. In logistics, for example, the adoption of robust, temperature-controlled containers has facilitated a shift from air to ocean freight, offering significant cost savings and a substantial reduction in environmental impact. This demonstrates how businesses can enhance sustainability and profitability while meeting regulatory expectations.
Pharma 4.0 and Compliance
The advent of Pharma 4.0 is further reshaping the compliance landscape. According to DeLapp, when discussing Pharma 4.0, the implementation of advanced technology and integration into the next industrial revolution begins with three key considerations:
- Understanding where the organization stands in its digital transformation journey
- Holistically analyzing data strategy and establishing clear objectives as life science organizations often operate within silos
- Establishing clear, strategic objectives and approaching progress as an iterative process instead of a one-off task.
Supply chain disruptions and tariffs present another layer of complexity. DeLapp notes, “Ultimately, it all comes down to building resilient supply chains.” He illustrates this with an example of a customer using SAP IBP to evaluate “what if” scenarios in preparation for tariffs, optimizing production to mitigate potential impacts.
Moreover, DeLapp states, “Data integrity is at the core of everything we do. Without reliable data, predictions and automation derived from it cannot be trusted.”
Challenges in Compliance Management
Personalized medicine introduces unique compliance challenges, particularly in traceability and data management. DeLapp emphasizes the importance of chain of custody and chain of identity in this segment. He highlights SAP Cell and Gene Therapy Orchestration as a solution that integrates critical functionalities to ensure smooth processes, temperature-controlled transit, and the integrity of bio specimens.
Integrating SAP S/4HANA and other digital solutions offers significant benefits for compliance management. DeLapp explained that SAP comes preconfigured with extensive industry best practices, particularly aligned with current GxP standards. This makes it inherently suitable for regulated industries. He also highlighted the NTT DATA Business Solutions Life Science Accelerator Package, which combines SAP’s activate methodology with GAMP 5, providing pre-built user requirement stories and validation templates to streamline implementation and ensure regulatory adherence.
Looking ahead, DeLapp foresees major compliance challenges stemming from reductions in federal boards like the FDA, leading to uncertainty in future regulations. He also points to the increasing complexity of the supply chain due to tariffs and customs regulations. To prepare clients for these shifts, DeLapp states, “NTT DATA Business Solutions works directly with our customers to help them stay ahead of these challenges. We accomplish this by actively participating on regulatory boards, so that we are not only participating in the community but also staying ahead of any changes or new regulations to ensure that our innovations are compliant.”
What This Means for SAPinsiders:
Leverage pre-configured GxP standards in SAP for a head start on compliance. SAP S/4HANA is designed with the life sciences industry in mind, offering a wealth of pre-configured functionalities that align with critical Good Practice (GxP) guidelines. This inherent focus significantly reduces the need for extensive custom development to meet regulatory requirements in areas like quality management, batch traceability, electronic signatures, and audit trails.
Streamline validation with solutions like the Integrated Life Science Accelerator. The validation of IT systems is a crucial and time-consuming aspect of life sciences compliance. NTT DATA Business Solutions offers a powerful advantage with their Life Science Accelerator Package that seamlessly integrates SAP’s Activate methodology for efficient project delivery with the industry-standard GAMP 5 framework for validation.
Unlock deeper insights and proactive compliance through holistic data integration. Life sciences organizations often struggle with data residing in disparate systems, hindering comprehensive analysis and proactive risk management. NTT DATA Business Solutions’ GxP Data Fabric Accelerator specifically addresses this challenge for SAP users. The holistic approach to data is exemplified in a customer scenario where integrating data from disparate systems like ERP, LIMS, and QMS, along with transportation data, enables the use of AI and machine learning to identify correlations impacting quality and yield. This data harmonization leads to proactive measures that enhance production efficiency.
